Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04436926 · ClinicalTrials.gov registry record · NA

Opioid Approach Bias Modification

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04436926 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04436926, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

To investigate the neurobiological mechanisms underlying opioid approach bias during a pilot RCT of opioid approach bias modification. The investigators are combining novel ultra-high field MRI technology with the promising treatment of modifying cognitive bias away from detrimental prescription drug use will generate novel neural data and potentially yield a new therapeutic tool to reduce problematic opioid use.

Interventions

  • BEHAVIORAL opioid approach bias modification
  • BEHAVIORAL sham training

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-03-01
Est. Completion 2023-11-30
Phase NA

What the Registry Record Tells You About NCT04436926

The ClinicalTrials.gov registry entry for NCT04436926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which opioid approach bias modification is the first listed.

NCT04436926 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04436926 about?

NCT04436926 is a clinical study titled "Opioid Approach Bias Modification". To investigate the neurobiological mechanisms underlying opioid approach bias during a pilot RCT of opioid approach bias modification. The investigators are combining novel ultra-high field MRI technology with the promising treatment of modifying cognitive bias away from detrimental prescription dru...

What is the current status of trial NCT04436926?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-03-01. Estimated completion is 2023-11-30.

What interventions are being tested in trial NCT04436926?

The interventions under investigation include: opioid approach bias modification (BEHAVIORAL), sham training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04436926?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.